Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients
Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2, Chronic Kidney Disease stage3
About this trial
This is an interventional treatment trial for Chronic Kidney Disease Stage 1
Eligibility Criteria
Inclusion Criteria
- Chronic kidney disease stage 1-4
- Agree to partake in the study signed informed consent forms for participation.
Exclusion Criteria:
- Can not use a smartphone
- Have impaired walking capacity
- Psychiatric disorder
- Have been hospitalized during the previous three months
Sites / Locations
- National Taiwan University Hospital Yunlin Branch
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention group
Control group
The intervention involved reminding the intervention group to upload their dietary diary every day. The researchers were trained by a dietitian and provided suggestions about diet and exercise to the intervention group. "LINE " is a mobile app operated by LINE Corporation. All users can use texts, images, video, and audio for contact at any time. A LINE group was created to deliver medical knowledge of diet and exercise. Each of the messages were guided by a diet manual for kidney disease (edited by Department of Dietetics, National Taiwan University Hospital Yunlin Branch). The intervention group also asked questions about CKD management, and a teleconsultation of health information was provided. A daily target of 7,500 steps was set and used to emphasize the correct concepts about exercise. Participants were inspired in the intervention group if someone achieved the target number of steps.
The participants of control group had a wearable device and could upload their dietary diary to the health management platform every day. But no "LINE" group was created, and no reminding.